Area of research
Internal Medicine · Immunology
Research interest
Research interests include Venous Thromboembolism Diagnosis and Management, Complement system in diseases, COVID-19 and healthcare impacts, and COVID-19 Clinical Research Studies.
Construction of donkey skin fibroblast immortalized cell line and comparative analysis with primary cells
Development of novel plasma proteomic biomarkers for cancer-associated thrombosis in an advanced cancer cohort.
The Impact of Anticoagulation in Patients With Isolated Cancer-Associated Splanchnic Vein Thrombosis: A Dual-Center Cohort Study.
Epidemiology of Cancer-Associated Venous Thromboembolism Across the United States.
Clinical Outcomes and Patterns of Care Among Patients With Newly Diagnosed Classical Hodgkin Lymphoma in a Safety-Net Health System
Temporal biomarker dynamics and clinical outcomes in transplant-associated thrombotic microangiopathy (TA-TMA)
Circulating tumor DNA predicts venous thromboembolism in patients with cancers
Clonal hematopoiesis of indeterminate potential and incidence of venous thromboembolism in older adults.
Clinical Factors Associated With Catheter-Related VTE in Patients Undergoing Hematopoietic Cell Transplantation: A Multi-Center Study.
Role and Use of Race in Artificial Intelligence and Machine Learning Models Related to Health.
Development and validation of venous thromboembolism–bidirectional encoder representations from transformers (VTE-BERT) natural language processing model
Incidence and risk of arterial thromboembolism in cancer patients from a safety-net healthcare system.
Racial and Ethnic Disparity for Cancer Mortality in General and Single-Payer Healthcare Systems in the United States.
Cancer-Associated Thrombosis: Surveying Patients' Awareness and Education Needs.
Table S1-S3 from Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors
Supplementary Figures and Table legends from Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors
Extent of Lymphadenectomy for Surgical Management of Right-Sided Colon Cancer: The Randomized Phase III RELARC Trial
Comparison of different machine learning classification models for predicting deep vein thrombosis in lower extremity fractures
Intracellular C5aR1 inhibits ferroptosis in glioblastoma through METTL3-dependent m6A methylation of GPX4
Spatial-temporal patterns and influencing factors for hemorrhagic fever with renal syndrome: A 16-year national surveillance analysis in China
Thrombosis risk prediction in lymphoma patients: A multi-institutional, retrospective model development and validation study.
Enhancing thromboprophylaxis after colorectal cancer surgery in China: Bridging the gap between evidence and implementation through pathway optimization
Trends and Updates on the Epidemiology of Cancer Associated Thrombosis: A Systematic Review.
Derivation and Validation of a Clinical Risk Assessment Model for Cancer-Associated Thrombosis in Two Unique US Health Care Systems
Derivation and Validation of a Clinical Risk Assessment Model for Cancer-Associated Thrombosis in Two Unique US Health Care Systems.
Incidence, prevention, risk factors, and prediction of venous thromboembolism in Chinese patients after colorectal cancer surgery: a prospective, multicenter cohort study
Epidemiology of Cancer-Associated Venous Thromboembolism in Patients With Solid and Hematologic Neoplasms in the Veterans Affairs Health Care System
External validation of a novel electronic risk score for cancer‐associated thrombosis in a comprehensive cancer center
Venous thromboembolism risk in cancer patients receiving first‐line immune checkpoint inhibitor versus chemotherapy
Development and validation of a risk model for hospital-acquired venous thrombosis: the Medical Inpatients Thrombosis and Hemostasis study